From: Diabetes management in Thailand: a literature review of the burden, costs, and outcomes
Estimate | Summary of the main features of the study | Reference |
---|---|---|
Direct and indirect costs | Â | Â |
Median and (mean) cost of illness per type of patient per year | Study year: Oct 2007- Sep 2008 | |
Independent: USD$ 124 (USD$ 598), SD 2152 | Reference year for estimate is the fiscal year 2008 | |
Disabled: USD$ 811 (USD$ 2,700), SD 4982 | Setting: Waritchaphum Hospital. A 30-bed public district hospital in Sakhon Nakhon province in northeastern Thailand | |
 | Sample and study design: 475 randomly selected diabetic patients. Prevalence-based cost of illness, societal perspective |  |
Median and (mean) cost of illness per patient (both disabled and independent) per year: USD 140 (USD$ 881),[82.01-552.50] | Study year: Oct 2007- Sep 2008 | |
This included 23% of direct medical cost, 40% of direct non-medical cost, and 37% of indirect cost | Reference year for estimate is the fiscal year 2008 | |
Informal care contributed to 28% of total cost of illness | Setting: Waritchaphum Hospital. A 30-bed public district hospital in Sakhon Nakhon province in northeastern Thailand. | |
 | Sample and study design: 475 randomly selected diabetic patients. Prevalence-based cost of illness, societal perspective |  |
Direct costs | Â | Â |
Average public treatment cost per patient per year was USD 95 | Study year: Oct 2007- Sep 2008 | [62] |
Drug cost was the highest cost component (25% of total cost), followed by inpatient cost (24%) and outpatient visit cost (17%). | Reference year for estimate is the fiscal year 2008 | |
 | Setting: Waritchaphum Hospital. A 30-bed public district hospital in Sakhon Nakhon province in northeastern Thailand. | |
 | Sample and study design: 475 randomly selected diabetic patients. Retrospective prevalence-based cost of illness study, provider perspective |  |
Annual average cost of illness (including patients with complications): USD$ 158 (THB 6,331) | Study year: October 2000-September 2001 | [52] |
Contribution to the total cost: 45% pharmacy services, 24% outpatient services, 16% inpatient services, 11% laboratory investigations. | Setting: 30-bed public community hospital in central Thailand | |
Annual cost for DMT2 and DMT1 patients with no complication USD$ 101 (THB 4,037) and USD$ 251 (THB 10,059) respectively | Sample and study design: 186 diabetes patients. Retrospective prevalence-based cost of illness study, provider perspective | Â |
Indirect costs | Â | Â |
Median and (mean) cost of informal care per month | Study year: 2008 | [38] same study as |
Opportunity cost approach: USD 27 (USD$ 37) | Setting: Waritchaphum Hospital. A 30-bed public district hospital in Sakhon Nakhon province in northeastern Thailand. | |
Proxy good method: | Sample and study design: 190 informal caregivers. Interview with carers, revealed preference method | |
USD$ 23 (USD 34) | Â | |
Average time spent on informal care was 112Â hours per month | Â | Â |